CD8A and neoplasm: In this model, the combination therapy successfully inhibited tumor growth and prolonged animal survival compared with either treatment alone, and was associated with an increase in the percentage of CD8+ tumor-infiltrating lymphocytes (TILs) as well as in the cytotoxic ability of NK cells [100].